z-logo
open-access-imgOpen Access
Human trophoblast cells express CD4 and are permissive for productive infection with HIV‐1
Author(s) -
DAVID F. J. E.,
AUTRAN B.,
TRAN H. C.,
MENU E.,
RAPHAEL M.,
DEBRE P.,
HSI B. L.,
WEGMAN T. G.,
BARRESINOUSSI F.,
CHAOUAT G.
Publication year - 1992
Publication title -
clinical & experimental immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.329
H-Index - 135
eISSN - 1365-2249
pISSN - 0009-9104
DOI - 10.1111/j.1365-2249.1992.tb03031.x
Subject(s) - permissive , trophoblast , immunology , human immunodeficiency virus (hiv) , biology , virology , immunopathology , pregnancy , genetics , placenta , fetus
SUMMARY The European collaborative study of HIV‐infected pregnant women in Europe now indicates a 13% risk of fetal HIV infection (originally thought to be about 30%, and possibly higher in some countries). Several reports suggest trans‐placental passage. However, the detailed mechanisms associated with such vertical transmission have not yet been clarified. We have examined the possibility that HIV enters placental tissue from maternal blood via binding to CD4 and Fc receptors (FcR) at the trophoblast level, allowing intraplaccntal infection. Here we report the detection of several FcR with distinct localization in the placental villus as well as CD4 surface expression on human trophoblast cells. In addition, we show that trophoblastic cells interact specifically with the gp120/gp160 viral envelope protein. By their tissue localization, these receptors could be responsible for the entry of HIV into the fetal placental cells. Furthermore, purified placental cells can be directly infected by HIV in vitro , and the infection is inhibited by soluble CD4. This suggests a crucial role of the CD4 receptor but an additional way of entry cannot be excluded. Such an in vitro model may be suitable for further studies concerning placental HIV transmission and its prevention.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here